Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600116951Phase 4Recruiting
Phase 4, randomised trial of remimazolam and propofol in None (3 arms), sponsored by 963rd Hospital of the Joint Logistic Support Force. Primary endpoint: hypotension. Started Jan 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600116951.